$ILMN Company News More reasons to like the Na
Post# of 72724
Posted On: 09/11/2014 1:10:22 PM
$ILMN Company News
More reasons to like the Nasdaq in September 3:14 p.m. Sept. 4, 2014 - The Trading Deck
Good times for stocks lie ahead 1:47 p.m. Aug. 28, 2014 - The Trading Deck
Roche to buy InterMune for $8.3 billion 10:42 p.m. Aug. 24, 2014 - Jonathan D. Rockoff
Raiffeisen rallies, miners slip: Europe movers 12:04 p.m. Aug. 21, 2014 - Sara Sjolin
Miners drop in London after weak China PMI 12:02 p.m. Aug. 21, 2014 - Sara Sjolin
Nasdaq needs to turn up the volume 11:59 a.m. July 17, 2014 - The Trading Deck
Growth stocks are doing most bullish thing they can 3:24 p.m. July 1, 2014 - The Trading Deck
S&P, Dow press uncharted territory 8:22 a.m. June 23, 2014 - Michael Ashbaugh
Stocks are poised for a jump higher 12:30 p.m. June 10, 2014 - The Trading Deck
What Apple needs next is this 1:28 p.m. May 8, 2014 - Cody Willard
Investors continue to pour out of biotech holdings 2:43 p.m. April 4, 2014 - Russ Britt
A stock that protects your identity and your portfolio 12:56 p.m. Feb. 3, 2014 - The Trading Deck
Let Ilumina brighten up your portfolio 4:02 p.m. Jan. 30, 2014 - The Trading Deck
Illumina gets mileage out of earnings as industry declines 11:51 a.m. Jan. 29, 2014 - Russ Britt
Illumina shares up on plan to tap $20 billion gene-sequencing market 1:06 p.m. Jan. 17, 2014 - Russ Britt
S&P 500 drops from record, but Nasdaq ekes out gain: Stock market live blog recap 5:02 p.m. Jan. 16, 2014 - blogs.marketwatch.com
S&P, Nasdaq rally from major support 12:09 p.m. Dec. 16, 2013 - Michael Ashbaugh
Illumina shares soar, Waters slides on diverging earnings reports 11:54 a.m. Oct. 22, 2013 - Russ Britt
Charting a sluggish, but bullish, August breakout 11:08 a.m. Aug. 5, 2013 - Michael Ashbaugh
Wednesday’s movers: Robust iPhone data lifts Apple 3:45 p.m. July 24, 2013 - Sue Chang
Cytokinetics (CYTK) Looks Strong: Stock Gains 17.2% - Tale of the Tape 8:44 a.m. Today - Zacks.com
Myriad Genetics Posts Encouraging myPath Melanoma Data - Analyst Blog 3:00 p.m. Sept. 10, 2014 - Zacks.com
10 Best “Strong Buy” Stocks — ILMN EQM XRS and more 4:15 a.m. Sept. 10, 2014 - InvestorPlace.com
Quiet Stocks Are Typical In Market Right Now 5:18 p.m. Sept. 8, 2014 - Investors Business Daily
Why Illumina (ILMN) Stock Is Gaining Today 10:56 a.m. Sept. 8, 2014 - TheStreet.com
IBD 50 Showing Little Distress, But Few Big Winners 5:45 p.m. Sept. 5, 2014 - Investors Business Daily
Celgene's Revlimid Impresses in Phase III NDMM Study - Analyst Blog 4:45 p.m. Sept. 5, 2014 - Zacks.com
Salix, Gilead Among 5 Top Medical Leaders To Watch 4:06 p.m. Sept. 5, 2014 - Investors Business Daily
Alexion Pharmaceuticals' Soliris Wins NICE Backing for aHUS - Analyst Blog 5:00 p.m. Sept. 4, 2014 - Zacks.com
3 Stocks Advancing The Health Care Sector 1:03 p.m. Sept. 4, 2014 - TheStreet.com
Transgenomic's Niche In Illumina's Universe 11:58 a.m. Sept. 4, 2014 - Seeking Alpha
Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead 5:28 p.m. Sept. 3, 2014 - Investors Business Daily
10 Best “Strong Buy” Stocks — LUV ILMN XRS and more 4:30 a.m. Sept. 3, 2014 - InvestorPlace.com
Synthetic Biologics (SYN) Looks Strong: Stock Gains 13.9% - Tale of the Tape 8:44 a.m. Sept. 2, 2014 - Zacks.com
Gilead, Jazz Among 4 Top Big Cap Medicals To Watch 7:02 a.m. Aug. 27, 2014 - Investors Business Daily
More Biotech Mergers: Roche to Acquire InterMune (ITMN) - Stocks in the News 4:43 p.m. Aug. 25, 2014 - Zacks.com
The 4 Companies Teaming Up For A New Tool To Fight Cancer 3:03 p.m. Aug. 25, 2014 - benzinga.com
Roche to Acquire Biotech Firm 12:00 p.m. Aug. 24, 2014 - The Wall Street Journal Interactive Edition
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update 10:34 a.m. Aug. 23, 2014 - Seeking Alpha
Illumina Joins Drugmakers To Make Cancer Test System 5:57 p.m. Aug. 22, 2014 - Investors Business Daily
Illumina, Inc. (NASDAQ: ILMN) to Ring The NASDAQ Stock Market Opening Bell 10:00 a.m. Sept. 9, 2014 - GlobeNewswire
Actionable Genome Consortium Forms with Cross Disciplinary Leaders from World-Renowned Cancer Institutions 6:30 a.m. Sept. 8, 2014 - BusinessWire - BZX
Favourable Rulings, Upcoming Conferences, Clinical Study Results, Drug Availability, and Tender Offers - Research Reports on United Therapeutics, Illumina, AstraZeneca, Eli Lilly and Abbott 9:20 a.m. Sept. 3, 2014 - PR Newswire - PRF
Illumina to Webcast Live Presentation at the Morgan Stanley Global Healthcare Conference 6:30 a.m. Aug. 27, 2014 - BusinessWire - BZX
Collaborations, Upcoming Seminar, Clinical Trial Results, Data Presentation Schedule - Research Reports on AstraZeneca, Illumina, Novartis, Lilly and Alexion 8:30 a.m. Aug. 26, 2014 - PR Newswire - PRF
Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase)-Global Forecast to 2018 6:02 p.m. Aug. 25, 2014 - PR Newswire - PRF
The Global Non-Invasive Prenatal Diagnostics Market 1:12 p.m. Aug. 19, 2014 - PR Newswire - PRF
Life Sciences Tools and Services Stocks in Motion -- Affymetrix, Agilent Technologies, Bruker, Illumina, and Sequenom 8:40 a.m. Aug. 18, 2014 - PR Newswire - PRF
Drug Approvals, Financial Results, Market Activity, New Mobile Applications, and Company Updates - Research Reports on Intercept, Exact Sciences, Thermo Fisher Scientific, Illumina and Agilent 9:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Dividends, New Leaderships, and Scheduled Conference Calls - Research Reports on St. Jude Medical, Endo, Cooper, Zoetis and Illumina 8:50 a.m. Aug. 11, 2014 - PR Newswire - PRF
New Product Launch, New Board Member, Major Contracts, Successful Testing, and Grants - Research Reports on Abbott, Illumina, General Dynamics, Raytheon and Northrop Grumman 8:50 a.m. Aug. 7, 2014 - PR Newswire - PRF
Critical Alerts For VoxelJet, Google, Orexigen Therapeutics, Illumina, and Activision Blizzard Released By InvestorsObserver 9:31 a.m. Aug. 5, 2014 - PR Newswire - PRF
UK to Become World Number One in DNA Testing with Plan to Revolutionise Fight Against Cancer and Rare Diseases 7:05 p.m. July 31, 2014 - BusinessWire - BZX
Illumina Appoints Jeff Huber to its Board of Directors 6:30 a.m. July 31, 2014 - BusinessWire - BZX
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 8:40 a.m. July 29, 2014 - PR Newswire - PRF
Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018 5:38 p.m. July 28, 2014 - PR Newswire - PRF
Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2014 4:07 p.m. July 23, 2014 - BusinessWire - BZX
Sidra to Help Qatar Grow as a Hub for Genetic Medicine 7:45 a.m. July 22, 2014 - BusinessWire - BZX
Berry Genomics and Illumina Co-Develop Integrated Next-Generation Sequencing System for Review and Approval by Chinese Regulatory Agency 6:30 a.m. July 21, 2014 - BusinessWire - BZX
Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx 8:10 a.m. July 17, 2014 - PR Newswire - PRF
More reasons to like the Nasdaq in September 3:14 p.m. Sept. 4, 2014 - The Trading Deck
Good times for stocks lie ahead 1:47 p.m. Aug. 28, 2014 - The Trading Deck
Roche to buy InterMune for $8.3 billion 10:42 p.m. Aug. 24, 2014 - Jonathan D. Rockoff
Raiffeisen rallies, miners slip: Europe movers 12:04 p.m. Aug. 21, 2014 - Sara Sjolin
Miners drop in London after weak China PMI 12:02 p.m. Aug. 21, 2014 - Sara Sjolin
Nasdaq needs to turn up the volume 11:59 a.m. July 17, 2014 - The Trading Deck
Growth stocks are doing most bullish thing they can 3:24 p.m. July 1, 2014 - The Trading Deck
S&P, Dow press uncharted territory 8:22 a.m. June 23, 2014 - Michael Ashbaugh
Stocks are poised for a jump higher 12:30 p.m. June 10, 2014 - The Trading Deck
What Apple needs next is this 1:28 p.m. May 8, 2014 - Cody Willard
Investors continue to pour out of biotech holdings 2:43 p.m. April 4, 2014 - Russ Britt
A stock that protects your identity and your portfolio 12:56 p.m. Feb. 3, 2014 - The Trading Deck
Let Ilumina brighten up your portfolio 4:02 p.m. Jan. 30, 2014 - The Trading Deck
Illumina gets mileage out of earnings as industry declines 11:51 a.m. Jan. 29, 2014 - Russ Britt
Illumina shares up on plan to tap $20 billion gene-sequencing market 1:06 p.m. Jan. 17, 2014 - Russ Britt
S&P 500 drops from record, but Nasdaq ekes out gain: Stock market live blog recap 5:02 p.m. Jan. 16, 2014 - blogs.marketwatch.com
S&P, Nasdaq rally from major support 12:09 p.m. Dec. 16, 2013 - Michael Ashbaugh
Illumina shares soar, Waters slides on diverging earnings reports 11:54 a.m. Oct. 22, 2013 - Russ Britt
Charting a sluggish, but bullish, August breakout 11:08 a.m. Aug. 5, 2013 - Michael Ashbaugh
Wednesday’s movers: Robust iPhone data lifts Apple 3:45 p.m. July 24, 2013 - Sue Chang
Cytokinetics (CYTK) Looks Strong: Stock Gains 17.2% - Tale of the Tape 8:44 a.m. Today - Zacks.com
Myriad Genetics Posts Encouraging myPath Melanoma Data - Analyst Blog 3:00 p.m. Sept. 10, 2014 - Zacks.com
10 Best “Strong Buy” Stocks — ILMN EQM XRS and more 4:15 a.m. Sept. 10, 2014 - InvestorPlace.com
Quiet Stocks Are Typical In Market Right Now 5:18 p.m. Sept. 8, 2014 - Investors Business Daily
Why Illumina (ILMN) Stock Is Gaining Today 10:56 a.m. Sept. 8, 2014 - TheStreet.com
IBD 50 Showing Little Distress, But Few Big Winners 5:45 p.m. Sept. 5, 2014 - Investors Business Daily
Celgene's Revlimid Impresses in Phase III NDMM Study - Analyst Blog 4:45 p.m. Sept. 5, 2014 - Zacks.com
Salix, Gilead Among 5 Top Medical Leaders To Watch 4:06 p.m. Sept. 5, 2014 - Investors Business Daily
Alexion Pharmaceuticals' Soliris Wins NICE Backing for aHUS - Analyst Blog 5:00 p.m. Sept. 4, 2014 - Zacks.com
3 Stocks Advancing The Health Care Sector 1:03 p.m. Sept. 4, 2014 - TheStreet.com
Transgenomic's Niche In Illumina's Universe 11:58 a.m. Sept. 4, 2014 - Seeking Alpha
Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead 5:28 p.m. Sept. 3, 2014 - Investors Business Daily
10 Best “Strong Buy” Stocks — LUV ILMN XRS and more 4:30 a.m. Sept. 3, 2014 - InvestorPlace.com
Synthetic Biologics (SYN) Looks Strong: Stock Gains 13.9% - Tale of the Tape 8:44 a.m. Sept. 2, 2014 - Zacks.com
Gilead, Jazz Among 4 Top Big Cap Medicals To Watch 7:02 a.m. Aug. 27, 2014 - Investors Business Daily
More Biotech Mergers: Roche to Acquire InterMune (ITMN) - Stocks in the News 4:43 p.m. Aug. 25, 2014 - Zacks.com
The 4 Companies Teaming Up For A New Tool To Fight Cancer 3:03 p.m. Aug. 25, 2014 - benzinga.com
Roche to Acquire Biotech Firm 12:00 p.m. Aug. 24, 2014 - The Wall Street Journal Interactive Edition
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update 10:34 a.m. Aug. 23, 2014 - Seeking Alpha
Illumina Joins Drugmakers To Make Cancer Test System 5:57 p.m. Aug. 22, 2014 - Investors Business Daily
Illumina, Inc. (NASDAQ: ILMN) to Ring The NASDAQ Stock Market Opening Bell 10:00 a.m. Sept. 9, 2014 - GlobeNewswire
Actionable Genome Consortium Forms with Cross Disciplinary Leaders from World-Renowned Cancer Institutions 6:30 a.m. Sept. 8, 2014 - BusinessWire - BZX
Favourable Rulings, Upcoming Conferences, Clinical Study Results, Drug Availability, and Tender Offers - Research Reports on United Therapeutics, Illumina, AstraZeneca, Eli Lilly and Abbott 9:20 a.m. Sept. 3, 2014 - PR Newswire - PRF
Illumina to Webcast Live Presentation at the Morgan Stanley Global Healthcare Conference 6:30 a.m. Aug. 27, 2014 - BusinessWire - BZX
Collaborations, Upcoming Seminar, Clinical Trial Results, Data Presentation Schedule - Research Reports on AstraZeneca, Illumina, Novartis, Lilly and Alexion 8:30 a.m. Aug. 26, 2014 - PR Newswire - PRF
Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase)-Global Forecast to 2018 6:02 p.m. Aug. 25, 2014 - PR Newswire - PRF
The Global Non-Invasive Prenatal Diagnostics Market 1:12 p.m. Aug. 19, 2014 - PR Newswire - PRF
Life Sciences Tools and Services Stocks in Motion -- Affymetrix, Agilent Technologies, Bruker, Illumina, and Sequenom 8:40 a.m. Aug. 18, 2014 - PR Newswire - PRF
Drug Approvals, Financial Results, Market Activity, New Mobile Applications, and Company Updates - Research Reports on Intercept, Exact Sciences, Thermo Fisher Scientific, Illumina and Agilent 9:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Dividends, New Leaderships, and Scheduled Conference Calls - Research Reports on St. Jude Medical, Endo, Cooper, Zoetis and Illumina 8:50 a.m. Aug. 11, 2014 - PR Newswire - PRF
New Product Launch, New Board Member, Major Contracts, Successful Testing, and Grants - Research Reports on Abbott, Illumina, General Dynamics, Raytheon and Northrop Grumman 8:50 a.m. Aug. 7, 2014 - PR Newswire - PRF
Critical Alerts For VoxelJet, Google, Orexigen Therapeutics, Illumina, and Activision Blizzard Released By InvestorsObserver 9:31 a.m. Aug. 5, 2014 - PR Newswire - PRF
UK to Become World Number One in DNA Testing with Plan to Revolutionise Fight Against Cancer and Rare Diseases 7:05 p.m. July 31, 2014 - BusinessWire - BZX
Illumina Appoints Jeff Huber to its Board of Directors 6:30 a.m. July 31, 2014 - BusinessWire - BZX
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 8:40 a.m. July 29, 2014 - PR Newswire - PRF
Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018 5:38 p.m. July 28, 2014 - PR Newswire - PRF
Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2014 4:07 p.m. July 23, 2014 - BusinessWire - BZX
Sidra to Help Qatar Grow as a Hub for Genetic Medicine 7:45 a.m. July 22, 2014 - BusinessWire - BZX
Berry Genomics and Illumina Co-Develop Integrated Next-Generation Sequencing System for Review and Approval by Chinese Regulatory Agency 6:30 a.m. July 21, 2014 - BusinessWire - BZX
Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx 8:10 a.m. July 17, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼